Mercaptamine and skin discolouration Patient Reports February 13, 2012

Mercaptamine Side Effects Report #5215547-8
Mercaptamine side effect was reported by a Physician from FRANCE on Jan 03, 2007. Male patient, 14 years of age, weighting 88.85 lb, was diagnosed with cystinosis and was treated with Mercaptamine. After drug was administered, patient experienced the following side effects: arthropathy, haemoglobin decreased, skin discolouration, skin fragility. Mercaptamine dosage: 1200 MG; QD; PO. During the same period patient was treated with CYSTEAMINE, ESOMEPRAZOLE MAGNESIUM, PHOSPHATE, ALFACALCIDOL, POTASSIUM CHLORIDE, CITRATE. Patient recovered.

Mercaptamine Side Effects Report #5243426-9
Mercaptamine side effect was reported by a Health Professional from FRANCE on Feb 01, 2007. Male patient, 14 years of age, weighting 88.85 lb, was diagnosed with cystinosis and was treated with Mercaptamine. After drug was administered, patient experienced the following side effects: arthropathy, creatinine renal clearance decreased, haemoglobin decreased, skin discolouration, skin fragility. Mercaptamine dosage: 1200 MG; DAILY; ORAL. During the same period patient was treated with CYSTEAMINE, ESOMEPRAZOLE MAGNESIUM, PHOSPHATE, ALFACALCIDOL, POTASSIUM CHLORIDE, CITRATE. Patient recovered.

Mercaptamine Side Effects Report #5066023-7
Mercaptamine side effect was reported by a Physician from FRANCE on July 11, 2006. Male patient, 14 years of age, was diagnosed with cystinosis and was treated with Mercaptamine. After drug was administered, patient experienced the following side effects: arthralgia, arthropathy, contusion, haemoglobin decreased, increased tendency to bruise, pain , skin discolouration. Mercaptamine dosage: 1200 MG; QD; PO. During the same period patient was treated with CYSTEAMINE, ESOMEPRAZOLE, PHOSPHATE, ALFACALCIDOL, CITRATE, POTASSIUM CHLORIDE. Patient recovered.

Mercaptamine Side Effects Report #4929557-9
Mercaptamine side effect was reported by a Health Professional from FRANCE on Feb 10, 2006. Female patient, child 11 years of age, was diagnosed with cystinosis and was treated with Mercaptamine. After drug was administered, patient experienced the following side effects: asthenia, diabetes mellitus, haemodialysis, myopathy, skin discolouration, skin disorder, x-ray limb abnormal. Mercaptamine dosage: unknown. During the same period patient was treated with MERCAPTAMINE BITARTRATE, MERCAPTAMINE BITARTRATE, INSULIN, INSULIN ISOPHANE BOVINE, SOMATROPIN, CALCIDIOL, EPOETIN BETA, SACCHARATED IRON OXIDE. Patient recovered.